Loading...
menu
Search
Features
Markets
News
Resources
Pricing
Home
ETF
SION
SION
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest SION ETF News Today | Earnings, Events & Price Alerts
SION News
Sionna Therapeutics Reports Q4 2025 Financial Results
1d ago
seekingalpha
Sionna Therapeutics Outlines 2026 CF Clinical Catalysts
Feb 15 2026
Yahoo Finance
Sionna Therapeutics CLO Jennifer Fitzpatrick Sells Shares Worth $415,330
Jan 13 2026
Fool
Sionna Therapeutics CLO Sells 10,250 Shares for Over $400K
Jan 13 2026
NASDAQ.COM
Sionna Therapeutics to Present at J.P. Morgan Healthcare Conference on January 13
Jan 05 2026
Globenewswire
Sionna Therapeutics Sells 33,356 Shares for $1.49M on Dec 24, 2025
Jan 03 2026
NASDAQ.COM
Orbimed Disposes of 33,356 Shares in Sionna Therapeutics for $1.49 Million
Jan 03 2026
Fool
Orbimed Sells 33,356 Shares of Sionna for $1.5 Million
Jan 03 2026
Yahoo Finance
Sionna Therapeutics Director Sells 33,356 Shares
Dec 30 2025
Yahoo Finance
Stocks Decline Amid Increasing Bond Yields
Dec 02 2025
NASDAQ.COM
Stocks Decline as Increasing Bond Yields Trigger Cautious Investor Sentiment
Dec 01 2025
NASDAQ.COM
Crude Oil Rises More Than 1%; November Sees Decline in ISM Manufacturing PMI
Dec 01 2025
Benzinga
SION Surpasses Average Analyst Expectations
Nov 24 2025
NASDAQ.COM
Sionna Therapeutics to Present Phase 1 Data for SION-719 and SION-451, Along with New Preclinical Findings on NBD1 Stabilizers' Effect on F508del-CFTR Half-Life at the 2025 North American Cystic Fibrosis Conference
Oct 24 2025
Yahoo Finance
SION Surpasses Average Analyst Expectations
Oct 22 2025
NASDAQ.COM
Sionna Therapeutics Launches Phase 2a PreciSION CF Trial to Assess NBD1 Stabilizer SION-719 in Combination with Standard Care for Cystic Fibrosis Patients
Oct 21 2025
Newsfilter
Show More News
